Pharmaceutical firm Cipla has reported a net profit of Rs 309 crore in the second quarter of FY12, a growth of 17.5% as compared to Rs 263 crore in the corresponding quarter of last fiscal.
Net sales jumped 9.6% to Rs 1,732 crore in the July-September quarter of FY12 versus Rs 1,580 crore in a year ago period.
Source: www.moneycontrol.com
Thanks,
Gaurav Agarwal
Head Dealer
DENIP Consultants Pvt Ltd
No comments:
Post a Comment